Current and Emerging Treatments for Autoimmune Hepatitis.
作者信息
Weinberg Ethan M
机构信息
Assistant Professor of Clinical Medicine Division of Gastroenterology and Hepatology University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania.
出版信息
Gastroenterol Hepatol (N Y). 2024 Mar;20(3):176-178.
Abstract
摘要
相似文献
1
Current and Emerging Treatments for Autoimmune Hepatitis.自身免疫性肝炎的当前及新出现的治疗方法
Gastroenterol Hepatol (N Y). 2024 Mar;20(3):176-178.
2
Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.自身免疫性肝炎的非标准药物及可行的新干预措施：第一部分。
Inflamm Allergy Drug Targets. 2012 Oct;11(5):337-50. doi: 10.2174/187152812803251006.
3
Emerging treatments for autoimmune hepatitis.自身免疫性肝炎的新兴治疗方法。
Curr Drug Targets Inflamm Allergy. 2002 Dec;1(4):317-26. doi: 10.2174/1568010023344526.
4
Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.自身免疫性肝炎中特异性分子和细胞干预的新机遇。
Dig Dis Sci. 2010 Oct;55(10):2712-26. doi: 10.1007/s10620-009-1122-8. Epub 2010 Jan 27.
5
Autoimmune hepatitis in 828 Brazilian children and adolescents: clinical and laboratory findings, histological profile, treatments, and outcomes.828 例巴西儿童和青少年自身免疫性肝炎：临床和实验室发现、组织学特征、治疗和结局。
J Pediatr (Rio J). 2019 Jul-Aug;95(4):419-427. doi: 10.1016/j.jped.2018.04.007. Epub 2018 May 30.
6
The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.自身免疫性肝病的肠道和胆道微生物组学：现有证据和概念。
Semin Immunopathol. 2022 Jul;44(4):485-507. doi: 10.1007/s00281-022-00936-6. Epub 2022 May 10.
7
Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.自身免疫性肝炎患者的关注点：需要更好的治疗、更多的教育和克服污名化。
Dig Dis Sci. 2023 Jan;68(1):87-97. doi: 10.1007/s10620-022-07525-5. Epub 2022 May 17.
8
Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management.自身免疫性肝炎的新兴治疗性生物标志物及其对当前和未来治疗管理的影响。
Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):547-564. doi: 10.1080/17474124.2018.1453356. Epub 2018 Mar 20.
9
Emerging novel treatments for autoimmune liver diseases.自身免疫性肝病的新型治疗方法不断涌现。
Hepatol Res. 2019 May;49(5):489-499. doi: 10.1111/hepr.13347. Epub 2019 May 1.
10
Emerging importance of autoimmune hepatitis in children in Taiwan, an endemic area for viral hepatitis.在台湾这个病毒性肝炎流行地区，自身免疫性肝炎在儿童中的重要性日益凸显。
Pediatr Neonatol. 2009 Apr;50(2):65-9. doi: 10.1016/S1875-9572(09)60035-8.
本文引用的文献
1
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.一项在初治自身免疫性肝炎患者中比较硫唑嘌呤与霉酚酸酯诱导缓解作用的开放性随机对照临床试验。
J Hepatol. 2024 Apr;80(4):576-585. doi: 10.1016/j.jhep.2023.11.032. Epub 2023 Dec 14.
2
Advances in Understanding and Managing Autoimmune Hepatitis: A Narrative Review.自身免疫性肝炎的认识与管理进展：一篇叙述性综述
Cureus. 2023 Aug 23;15(8):e43973. doi: 10.7759/cureus.43973. eCollection 2023 Aug.
3
Autoimmune hepatitis and metabolic syndrome-associated disease development: a U.S. cohort study.自身免疫性肝炎与代谢综合征相关疾病的发生：一项美国队列研究。
Aliment Pharmacol Ther. 2022 Oct;56(7):1183-1193. doi: 10.1111/apt.17191. Epub 2022 Aug 16.
4
Established and novel therapeutic options for autoimmune hepatitis.自身免疫性肝炎的既定和新型治疗选择。
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):315-326. doi: 10.1016/S2468-1253(20)30328-9. Epub 2021 Feb 8.
5
Review article: experimental therapies in autoimmune hepatitis.综述文章：自身免疫性肝炎的实验性治疗。
Aliment Pharmacol Ther. 2020 Oct;52(7):1134-1149. doi: 10.1111/apt.16035. Epub 2020 Aug 14.
6
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group.利妥昔单抗治疗难治性自身免疫性肝炎的疗效：国际自身免疫性肝炎小组的结果
JHEP Rep. 2019 Nov 5;1(6):437-445. doi: 10.1016/j.jhepr.2019.10.005. eCollection 2019 Dec.
7
Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.布地奈德在自身免疫性肝炎患者的对照试验中比泼尼松更有效地诱导缓解。
Gastroenterology. 2010 Oct;139(4):1198-206. doi: 10.1053/j.gastro.2010.06.046. Epub 2010 Jun 22.
Zotero 插件